Table 1.
Mediator | Description | Effect | Reference |
---|---|---|---|
Disulfiram / NSA | Disulfiram modified the Cys191 residue of GSDMD, thereby inhibiting the pore-forming activity and liposome leakage of GSDMD | Disulfiram can inhibit IL-1β secretion in iBMDM and THP-1 cells, and improve the survival rate of mice with LPS-induced sepsis | [80, 81, 84] |
DMF | DMF reacts with GSDMD at critical cysteine residues to form S-(2-succinyl)-cysteine | In mice, the administration of DMF protects against sepsis shock | [83] |
TPNs | TPNs inhibit pyroptosis by blocking GSDMD-NT oligomerization | TPNs block canonical and noncanonical inflammasomes-induced pyroptosis in primary macrophages and THP-1 cells in a dose-dependent manner. TPNs treatment increases survival and body temperature in septic mice | [8] |
Mg2+ | Mg2+ blocks Ca2 + influx by inhibiting the ATP-gated Ca2 + channel P2X7, thereby impeding the function of GSDMD-NT | In HEK293T cells, Mg2 + inhibits GSDMD-NT membrane binding and oligomerization and protects against LPS-induced septic shock | [85] |
IL-6 | IL-6 inhibits caspase-3-GSDME and caspase-1-GSDMD | IL-6 protects streptococcus pneumoniae-induced pyroptosis and inflammatory injury in lung macrophages | [86] |
TRIM21 | The PRY-SPRY domain of TRIM21 interacts with GSDMD, maintains stable expression of GSDMD in the resting state, and induces GSDMD-N aggregation during pyroptosis | TRIM21-deficient cells have a reduced inflammasome-activated response, and mice with TRIM21 gene ablation are protected from LPS-induced inflammation and DSS-induced colitis | [87] |
GSDMD Gasdermin D, DMF dimethyl fumarate, TPNs tea polyphenols nanoparticles, Cys191 191-position cysteine, HEK293T human embryonic kidney cells, IL-6 Interleukin 6, TRIM21 tripartite motif 21, DSS dextran sulfate sodium salt, LPS lipopolysaccharide